PTSD, Social Anxiety Disorder (SAD), Pain
NYU Grossman School of Medicine, NYU
New York, USA
Clinical studies at the NYU Grossman school of Medicine are evaluating our investigational drug Nantheia™A1002 for PTSD (Principal Investigators: Charles Marmar MD, and Esther Blessings MD., Ph.D), and Radiculopathic Pain (Prinicpal Investigator: Stephen Ross, MD), and evaluating our investigational drug Nantheia™ ATL5 for Social Anxiety Disorder (Principal Investigators: Naomi Simon MD, M.Sc., and Esther Blessing MD, Ph.D.)
Opioid Use Disorder (OUD)
Geffen School of Medicine, UCLA
Los Angeles, CA, USA
A clinical study at the Geffen School of Medicine, UCLA, is evaluating the safety and tolerability of Nantheia™ ATL5 for Opioid Use Disorder (Principal Investigators: Edythe London, Ph.D. Additionally, this study seeks to ascertain the efficacy of Nantheia™ATL5 in mitigating opioid cravings.
Opioid Use Disorder
Icahn School of Medicine, Mt Sinai, NYC
New York, USA
Mt. Sinai have recently completed a phase 1 trial evaluating the Pharmacokinetic Profile of Nantheia™ ATL5 versus Epidiolex™. Results from this study will be published in the near future.
PTSD
University of Nebraska Medical Center
Omaha, Nebraska, USA
At the University of Nebraska Medical Center, a clinical trial is underway to evaluate Nantheia™ ATL5 for PTSD (Principal Investigator: Mathew Rizzo, MD, FAAN,FANA.) This is our second PTSD study focused on PTSD.
University of Florida
Tampa Bay, FL, USA
At the University of Florida, we are undertaking additional preclinical studies (Principal Investigator: Mark Kindy Ph.D.,) with our proprietary Liquid Structure™ cannabinoid formulations to further our understanding of the mode of action of our proprietary formulations in the body.
Phase I Study and Preclinical Study
Hadassah Hospital
Jerusalem, Israel
Hadassah Hospital completed a Phase 1 trial, assessing the bioavailability and safety of of our Liquid Structure™ cannabidiol formulations, versus CBD in Olive Oil, in 2020 (Principal Investigator; Professor Caraco MD.) Recently we have completed additional preclinical studies at Haddassah (Principal Investigator Osmat Hazan Ph.D) exploring modes of action for our Liquid Structure ™ formulations.
Copyright © 2024 ANANDA Scientific, Inc. All Rights Reserved.
